Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders

Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders

It mainly comprises the application of this product as a therapeutic agent used to treat patients with arteriosclerosis and/or re-stenosis that suffer a serious risk of occlusion of the vessels affected by the disease. Said product can be administered orally or parenterally, combined with other drug...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PRIEGO FDEZ. DEL CAMPO, JAIME, SANTOS GILL, LUIS, SUNKEL LETELIER, CARLOS, FAU DE CASA-JUANA MUNOZ, MIGUEL, ORTEGA NAVARRETE, PILAR, CILLERO CORRAL
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It mainly comprises the application of this product as a therapeutic agent used to treat patients with arteriosclerosis and/or re-stenosis that suffer a serious risk of occlusion of the vessels affected by the disease. Said product can be administered orally or parenterally, combined with other drugs or alone, to patients with arteriosclerotic disease to reduce the atheromatous lesion as well as to prevent re-stenosis of the blood vessels.